Log in or Sign up for Free to view tailored content for your specialty!
Retina/Vitreous News
Children with high myopia have greater foveal thickness in inner retina
The progression of myopia among school-aged children in China appeared to primarily affect changes in inner retinal thickness over the course of 1 year, according to research.
FDA approves Enzeevu, aflibercept biosimilar for neovascular AMD
The FDA approved the Enzeevu 2 mg vial kit and prefilled syringe for intravitreal injection for the treatment of neovascular age-related macular degeneration, according to a press release from Sandoz.
Log in or Sign up for Free to view tailored content for your specialty!
Success of myopic traction maculopathy surgery depends on morphology, timing
When managing myopic traction maculopathy, the timing of surgery should be carefully evaluated, avoiding early or delayed intervention, according to a speaker at the American Society of Retina Specialists annual meeting.
VIDEO: MCO-010 for retinitis pigmentosa improves vision in phase 2b/3 study
In this Healio Video Perspective from the ASRS meeting, Michael A. Singer, MD, of the University of Texas Health Science Center in San Antonio, discusses topline results for MCO-010 for the treatment of retinitis pigmentosa.
Prevalence of AMD-related vision loss expected to increase as population ages
While the prevalence of blindness due to age-related macular degeneration decreased globally from 2000 to 2020, researchers warn that the social and economic impact of AMD may grow as the population ages.
VIDEO: AVD-104 shows encouraging results in phase 2/3 study
In this video, Rishi P. Singh, MD, discusses results from part 1 of the phase 2/3 SIGLEC trial assessing AVD-104 for geographic atrophy, presented at the ASRS annual meeting in Stockholm.
Healio Minute Podcast, DME/Retina Edition: Top Headlines - Week of August 5, 2024
In this edition, sozinibercept combination therapy shows durability, comparable improvements with aflibercept and more.
Ocular Therapeutix receives FDA nod for SOL-R registrational study of Axpaxli
Ocular Therapeutix obtained FDA support to use the phase 3 SOL-R trial as the next step in the regulatory process for Axpaxli, according to a press release.
Q&A: Susvimo delivers immediate durability after implantation in wet AMD
Nearly 2 years after it voluntarily recalled Susvimo, Genentech recently announced plans to reintroduce the implant.
VIDEO: OTX-TKI for NPDR shows promising safety, tolerability at 48 weeks
In this Healio Video Perspective from the ASRS meeting, Dilsher Dhoot, MD, of California Retina Consultants discusses interim safety and efficacy results for OTX-TKI for the treatment of nonproliferative diabetic retinopathy.
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read